Cargando…
From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
Parkinson’s Disease (PD) is a prevalent neurodegenerative disorder that is characterized pathologically by the loss of A9-specific dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Despite intensive research, the etiology of PD is currently unresolved, and the d...
Autores principales: | Yeap, Yee Jie, Teddy, Tng J. W., Lee, Mok Jung, Goh, Micaela, Lim, Kah Leong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917335/ https://www.ncbi.nlm.nih.gov/pubmed/36768843 http://dx.doi.org/10.3390/ijms24032523 |
Ejemplares similares
-
Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
por: Becerra-Calixto, Andrea, et al.
Publicado: (2023) -
Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids
por: Shang, Jia, et al.
Publicado: (2022) -
Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020) -
The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021) -
High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
por: Sarrafha, Lily, et al.
Publicado: (2021)